Krishnapriya Nawal's Insider Trades & SAST Disclosures
Krishnapriya Nawal's most recent trade in Mangalam Drugs and Organics Ltd. was a Acquisition of 5,000 Equity Shares done at an average price of Rs. 133 . Disclosure was reported to the exchange on Jan. 2, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Krishnapriya Nawal in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mangalam Drugs | Krishnapriya Nawal | Promoters Immediate Relative | Acquisition | 02 Jan 2023 | 5,000 | 5,000 (0.03%) | 0.03% | 133 | 665,000 | 29 Dec 2022 29 Dec 2022 |
Insider Trading | Equity Shares | Gift |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.